BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33481388)

  • 1. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum.
    Urano M; Nakaguro M; Yamamoto Y; Hirai H; Tanigawa M; Saigusa N; Shimizu A; Tsukahara K; Tada Y; Sakurai K; Isomura M; Okumura Y; Yamaguchi H; Matsubayashi J; Nagao T
    Am J Surg Pathol; 2019 Jul; 43(7):984-994. PubMed ID: 30994537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
    Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Nagao T
    Surg Pathol Clin; 2021 Mar; 14(1):97-109. PubMed ID: 33526226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
    Pareja F; Toss MS; Geyer FC; da Silva EM; Vahdatinia M; Sebastiao APM; Selenica P; Szatrowski A; Edelweiss M; Wen HY; Mihai R; Varga Z; Foschini MP; Rubin BP; Ellis IO; Chandarlapaty S; Jungbluth AA; Brogi E; Weigelt B; Reis-Filho JS; Rakha EA
    Histopathology; 2020 May; 76(6):865-874. PubMed ID: 31887226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
    El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
    Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation.
    Rupp NJ; Brada M; Skálová A; Bode B; Broglie MA; Morand GB; Rechsteiner M; Freiberger SN
    Head Neck Pathol; 2020 Jun; 14(2):554-558. PubMed ID: 31309433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRAS Q61R immunohistochemical staining in thyroid pathology: sensitivity, specificity and utility.
    Saliba M; Katabi N; Dogan S; Xu B; Ghossein RA
    Histopathology; 2021 Oct; 79(4):650-660. PubMed ID: 33960437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical analysis of 6 cases of a new histologic variant.
    Shinozaki A; Nagao T; Endo H; Kato N; Hirokawa M; Mizobuchi K; Komatsu M; Igarashi T; Yokoyama M; Masuda S; Sano K; Izumi M; Fukayama M; Mukai K
    Am J Surg Pathol; 2008 Jun; 32(6):913-23. PubMed ID: 18425042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRAS mutations in epithelial-myoepithelial carcinoma.
    Chiosea SI; Miller M; Seethala RR
    Head Neck Pathol; 2014 Jun; 8(2):146-50. PubMed ID: 24277618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.
    Felisiak-Goląbek A; Inaguma S; Kowalik A; Wasąg B; Wang ZF; Zięba S; Pięciak L; Ryś J; Kopczynski J; Sarlomo-Rikala M; Góźdź S; Lasota J; Miettinen M
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):40-45. PubMed ID: 29206715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma.
    Mäkelä R; Arjonen A; Suryo Rahmanto A; Härmä V; Lehtiö J; Kuopio T; Helleday T; Sangfelt O; Kononen J; Rantala JK
    Neoplasia; 2020 Sep; 22(9):390-398. PubMed ID: 32645560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological analysis of 10 cases of salivary gland epithelial-myoepithelial carcinoma.
    Wang F; Li B; Wang Y; Shen Y; Yang H
    Medicine (Baltimore); 2020 Oct; 99(41):e22671. PubMed ID: 33031333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of NRAS(Q61R) protein in follicular-patterned thyroid tumors.
    Oishi N; Kondo T; Vuong HG; Nakazawa T; Mochizuki K; Kasai K; Inoue T; Tahara I; Hirokawa M; Miyauchi A; Katoh R
    Hum Pathol; 2016 Jul; 53():51-7. PubMed ID: 26980032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS; Lee YH; Jin YT; Kuo YJ
    Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
    Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
    Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial myoepithelial carcinoma of the parotid gland with malignant ductal and myoepithelial components arising in a pleomorphic adenoma: a case report with cytologic, histologic and immunohistochemical correlation.
    Daneshbod Y; Negahban S; Khademi B; Daneshbod K
    Acta Cytol; 2007; 51(5):807-13. PubMed ID: 17910353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.